Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Hydroxychloroquine Market, by Region, 2020-2030 (USD Billion)
1.2.2. Hydroxychloroquine Market, by Product Type , 2020-2030 (USD Billion)
1.2.3. Hydroxychloroquine Market, by Distribution Channel , 2020-2030 (USD Billion)
1.2.4. Hydroxychloroquine Market, by Disease , 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Hydroxychloroquine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Hydroxychloroquine Market Dynamics
3.1. Hydroxychloroquine Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of Malaria
3.1.1.2. Increasing number of clinical trials
3.1.1.3. Expanding therapeutic applications
3.1.2. Market Challenges
3.1.2.1. Side effects associated with hydroxychloroquine
3.1.3. Market Opportunities
3.1.3.1. Advancement in formulation of anti-parasite drugs
3.1.3.2. Rising awareness for generic drugs
Chapter 4. Global Hydroxychloroquine Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Hydroxychloroquine Market, by Product Type
5.1. Market Snapshot
5.2. Global Hydroxychloroquine Market by Product Type , Performance – Potential Analysis
5.3. Global Hydroxychloroquine Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
5.4. Hydroxychloroquine Market, Sub Segment Analysis
5.4.1. Tablet
5.4.2. Active Pharmaceutical Ingredients
Chapter 6. Global Hydroxychloroquine Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Hydroxychloroquine Market by Distribution Channel , Performance – Potential Analysis
6.3. Global Hydroxychloroquine Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Hydroxychloroquine Market, Sub Segment Analysis
6.4.1. Hospital Pharmacy
6.4.2. Online Pharmacy
6.4.3. Specialty Drug Store
6.4.4. Retail Pharmacy
Chapter 7. Global Hydroxychloroquine Market, by Disease
7.1. Market Snapshot
7.2. Global Hydroxychloroquine Market by Disease , Performance – Potential Analysis
7.3. Global Hydroxychloroquine Market Estimates & Forecasts by Disease 2020-2030 (USD Billion)
7.4. Hydroxychloroquine Market, Sub Segment Analysis
7.4.1. Malaria
7.4.2. Rheumatoid Arthritis
7.4.3. Lupus Erythematosus
7.4.4. Coronavirus
7.4.5. Others
Chapter 8. Global Hydroxychloroquine Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Hydroxychloroquine Market, Regional Market Snapshot
8.4. North America Hydroxychloroquine Market
8.4.1. U.S. Hydroxychloroquine Market
8.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.1.3. Disease breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Hydroxychloroquine Market
8.5. Europe Hydroxychloroquine Market Snapshot
8.5.1. U.K. Hydroxychloroquine Market
8.5.2. Germany Hydroxychloroquine Market
8.5.3. France Hydroxychloroquine Market
8.5.4. Spain Hydroxychloroquine Market
8.5.5. Italy Hydroxychloroquine Market
8.5.6. Rest of Europe Hydroxychloroquine Market
8.6. Asia-Pacific Hydroxychloroquine Market Snapshot
8.6.1. China Hydroxychloroquine Market
8.6.2. India Hydroxychloroquine Market
8.6.3. Japan Hydroxychloroquine Market
8.6.4. Australia Hydroxychloroquine Market
8.6.5. South Korea Hydroxychloroquine Market
8.6.6. Rest of Asia Pacific Hydroxychloroquine Market
8.7. Latin America Hydroxychloroquine Market Snapshot
8.7.1. Brazil Hydroxychloroquine Market
8.7.2. Mexico Hydroxychloroquine Market
8.8. Middle East & Africa Hydroxychloroquine Market
8.8.1. Saudi Arabia Hydroxychloroquine Market
8.8.2. South Africa Hydroxychloroquine Market
8.8.3. Rest of Middle East & Africa Hydroxychloroquine Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Cadila Healthcare Limited
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Hikma Pharmaceuticals PLC
9.3.3. Indian Pharmaceutical Combine Association Laboratories Ltd
9.3.4. Mylan N.V
9.3.5. Novartis AG
9.3.6. Pfizer Inc
9.3.7. Sanofi S.A.
9.3.8. Taj Pharma Group
9.3.9. Teva Pharmaceutical Industries Ltd
9.3.10. Torrent Pharmaceuticals Limited
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/